Future directions in preclinical and translational cancer neuroscience research.

Demir, Ihsan Ekin; Mota Reyes, Carmen; Alrawashdeh, Wasfi; Ceyhan, Güralp O; Deborde, Sylvie; Friess, Helmut; Görgülü, Kivanç; Istvanffy, Rouzanna; Jungwirth, David; Kuner, Rohini; Maryanovich, Maria; Na'ara, Shorook; Renders, Simon; Saloman, Jami L; Scheff, Nicole N; Steenfadt, Hendrik; Stupakov, Pavel; Thiel, Vera; Verma, Divij; Yilmaz, Bengi Su; White, Ruth A; Wang, Timothy C; Wong, Richard J; Frenette, Paul S; Gil, Ziv; Davis, Brian M

Demir, Ihsan Ekin; Mota Reyes, Carmen; Alrawashdeh, Wasfi; Ceyhan, Güralp O; Deborde, Sylvie; Friess, Helmut; Görgülü, Kivanç; Istvanffy, Rouzanna; Jungwirth, David; Kuner, Rohini; Maryanovich, Maria; Na'ara, Shorook; Renders, Simon; Saloman, Jami L; Scheff, Nicole N; Steenfadt, Hendrik; Stupakov, Pavel; Thiel, Vera; Verma, Divij; Yilmaz, Bengi Su; White, Ruth A; Wang, Timothy C; Wong, Richard J; Frenette, Paul S; Gil, Ziv; Davis, Brian M.

Affiliation

Demir IE; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. ekin.demir@tum.de.
Mota Reyes C; Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey. ekin.demir@tum.de.
Alrawashdeh W; German Cancer Consortium, Partner Site Munich, Munich, Germany. ekin.demir@tum.de.
Ceyhan GO; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. ekin.demir@tum.de.
Deborde S; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Friess H; German Cancer Consortium, Partner Site Munich, Munich, Germany.
Görgülü K; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Istvanffy R; Department of HPB and Transplant Surgery, The Freeman Hospital, Newcastle upon Tyne, UK.
Jungwirth D; Department of General Surgery, HPB-Unit, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.
Kuner R; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Maryanovich M; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Na'ara S; German Cancer Consortium, Partner Site Munich, Munich, Germany.
Renders S; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Saloman JL; Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Scheff NN; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Steenfadt H; German Cancer Consortium, Partner Site Munich, Munich, Germany.
Stupakov P; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Thiel V; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Verma D; German Cancer Consortium, Partner Site Munich, Munich, Germany.
Yilmaz BS; CRC 1321 Modeling and Targeting Pancreatic Cancer, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
White RA; Department of Molecular Pharmacology, Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Wang TC; Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY, USA.
Wong RJ; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Frenette PS; Department of Otolaryngology, Head and Neck Surgery, and the Laboratory for Applied Cancer Research, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel.
Gil Z; Head and Neck Center, Rambam Healthcare Campus, Haifa, Israel.
Davis BM; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.

Nat Cancer ; 1: 1027-1031, 2021 11.

Article de En | MEDLINE | ID: mdl-34327335

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Neurosciences / Tumeurs Type d'étude: Guideline / Prognostic_studies Limites: Humans Langue: En Journal: Nat Cancer Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google